News

Hamilton College researchers have identified molecules that have been shown to be effective in the fight against breast cancer.

AviaraDx publishes a 357 patient study showing independent roles of two-gene ratio in predicting clinical outcome in ER-positive breast cancer patients.

Through handheld electronic messaging, clinicians now have access to evidence- based recommendations that support decision-making at the point of care.

The Company has appointed senior pharmaceutical industry professionals to establish its own personalized medicines operations in US.

The Andrea and Charles Bronfman Philanthropies have given $12.5 million to establish the Institute for Personalized Medicine at Mount Sinai.

A multi-million pound visionary medical project that will recruit 500,000 people across Britain to help find out much more about curing many life threatening and debilitating diseases gets underway in Manchester.

Both companies have signed a multi-year collaboration to jointly identify targets for the treatment of Alzheimer’s disease with the Research Institute of Molecular Pathology in Vienna.

Biosite will have access to Compugen’s diagnostic and immunoassay biomarkers under a renewed and expanded partnership and licensing agreement.

Carl Zeiss has acquired the equipment business of the US Company Clarient to strengthen its clinical cancer diagnostics and cancer research.

Medical College of Georgia researchers will use a test to measure a tumor's aggressiveness in more than 10,000 women to identify the patients who need chemotherapy.